MSF's Suerie Moon spoke in front of a US Senate Committee on promoting new treatments & cures for neglected diseases read more
NEW: The 13th Edition of Untangling the Web of Antiretroviral Price Reductions is now available download it here
VIDEO: MSF's community approach to treating malnutrition in Niger watch it here
WHO's work on the financing of medical research and development is given a fresh start read more
MSF Letter to GFATM on concerns over scale-up of AIDS treatment in light of Board of Directors Meeting read more
New European Parliament Working Group on Innovation & Access launches with support of Access Campaign read more
|
 |
|
 |
Below is a list of the companies that produce the antiretrovirals we need in the patent pool.
Click on each company to see which drugs they produce and why we need them for the pool
Abbott Laboratories
Boehringer Ingelheim
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson/Tibotec Pharmaceuticals
Merck & Co
Pfizer Inc.
Sequoia Pharmaceuticals Inc.
FATAL FLAWS: How Kenya's 2008 Anti-Counterfeit Act could endanger access to medicines 
Presenation: Missing ARVs for HIV/AIDS treatment in 2009 - Unitaid Patent Pool Briefing
HIV/AIDS treatment in developing countries: the battle for long-term survival has just begun
